Hematology

Latest News

ACIP Votes to Lift Pause on J&J COVID-19 Vaccine
ACIP Votes to Lift Pause on J&J COVID-19 Vaccine

April 23rd 2021

The CDC's Advisory Committee on Immunization Practices voted to uphold the original language of the emergency use authorization for Johnson & Johnson's COVID-19 vaccination, and is possible the 1-dose vaccine could resume Saturday.

Carfilzomib, Bortezomib Combo Shows Potential for Reducing Tumor Growth in Melanoma Cells
Carfilzomib, Bortezomib Combo Shows Potential for Reducing Tumor Growth in Melanoma Cells

April 15th 2021

CDC, FDA Call for Pause of J&J COVID-19 Vaccine After Safety Concerns Around Clotting
CDC, FDA Call for Pause of J&J COVID-19 Vaccine After Safety Concerns Around Clotting

April 13th 2021

Bortezomib Appears to Increase Fall Risk in Elderly Patients With MM, Study Suggests
Bortezomib Appears to Increase Fall Risk in Elderly Patients With MM, Study Suggests

April 9th 2021

FDA Approves Isatuximab, Carfilzomib, Dexamethasone Combination for RRMM
FDA Approves Isatuximab, Carfilzomib, Dexamethasone Combination for RRMM

April 3rd 2021

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.